TN2011000151A1 - Hiv integrase inhibitors - Google Patents
Hiv integrase inhibitorsInfo
- Publication number
- TN2011000151A1 TN2011000151A1 TN2011000151A TN2011000151A TN2011000151A1 TN 2011000151 A1 TN2011000151 A1 TN 2011000151A1 TN 2011000151 A TN2011000151 A TN 2011000151A TN 2011000151 A TN2011000151 A TN 2011000151A TN 2011000151 A1 TN2011000151 A1 TN 2011000151A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compounds
- hiv
- hiv integrase
- inhibitors
- integrase inhibitors
- Prior art date
Links
- 229940099797 HIV integrase inhibitor Drugs 0.000 title 1
- 239000003084 hiv integrase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 208000030507 AIDS Diseases 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 108010002459 HIV Integrase Proteins 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940042443 other antivirals in atc Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I), wherein X1, X2, Y, R1A, R1B, R2 and R3 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset or progression of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se (or as hydrates or solvates thereof) or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2009/059306 WO2010042391A2 (en) | 2008-10-06 | 2009-10-02 | Hiv integrase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2011000151A1 true TN2011000151A1 (en) | 2012-09-05 |
Family
ID=55024437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TN2011000151A TN2011000151A1 (en) | 2009-10-02 | 2011-03-30 | Hiv integrase inhibitors |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2011000151A1 (en) |
-
2011
- 2011-03-30 TN TN2011000151A patent/TN2011000151A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD4625B1 (en) | 5-Phenoxy-3H-pyrimidin-4-one derivatives and their use as HIV reverse transcriptase inhibitors | |
| TN2012000455A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| MX2009006285A (en) | Non-nucleoside reverse transcriptase inhibitors. | |
| MX2019007262A (en) | Antiviral benzyl-amine phosphodiamide compounds. | |
| WO2006103399A8 (en) | Hiv integrase inhibitors | |
| WO2010042391A3 (en) | Hiv integrase inhibitors | |
| WO2008054605A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| WO2005086700A3 (en) | Hiv integrase inhibitors | |
| MY192607A (en) | Antiviral beta-amino acid ester phosphodiamide compounds | |
| WO2007146230A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| TW200738702A (en) | HIV reverse transcriptase inhibitors | |
| WO2006121831A3 (en) | Hiv integrase inhibitors | |
| WO2011025683A8 (en) | Hiv integrase inhibitors | |
| MX2016012915A (en) | Prodrugs of hiv reverse transcriptase inhibitors. | |
| WO2009042094A3 (en) | Hiv protease inhibitors | |
| ATE517899T1 (en) | HIV INTEGRASE INHIBITORS | |
| WO2007050510A3 (en) | Hiv integrase inhibitors | |
| WO2007002458A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| WO2007002481A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| TN2011000151A1 (en) | Hiv integrase inhibitors | |
| WO2007021629A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| WO2007002368A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| TW200640460A (en) | HIV integrase inhibitors | |
| TNSN06270A1 (en) | Hiv integrase inhibitors | |
| UA108495C2 (en) | Reverse transcriptase nucleoside inhibitors |